News

Interview:
In this interview, PharmaTelevision's Fintan Walton talks to Nicholas Barker, President and CEO of
The GI Company. Nicholas talks about the company’s lead programme, known as Intestinal Trefoil Factor... View the PharmTelevision interview.

Press Releases:

June 30, 2008:
The GI Company Reports Additional Phase II Clinical Data
of Intestinal Trefoil Factor (rhITF) Oral Spray for Oral Mucositis

June 16, 2008:
The GI Company to Present Phase I / II Oral Mucositis Data
on rhITF at MASCC / ISOO Annual Meeting

June 2, 2008:
The GI Company to Present at the BIO 2008 International Convention

June 2, 2008:
The GI Company Reports Significant Reduction in Occurrence
of Oral Mucositis in Phase II Study Presented at ASCO

May 16, 2008:
The GI Company Reports Significant Reduction in Occurrence of
Oral Mucositis in Phase II Study; Abstract Posted Online at ASCO.org

April 7, 2008:
The GI Company to Present Phase I & II Oral Mucositis Data at MASCC / ISOO Annual Meeting

March 26, 2008:
The GI Company to Present Phase II Oral Mucositis Data at ASCO Annual Meeting

February 12, 2008:
The GI Company to Present Corporate Update at BIO-Europe Spring

January 17, 2008:
The GI Company to Attend the 5th Annual Bio Asia Partnering Conference

January 7, 2008:
The GI Company Retains Burrill & Company to Evaluate Strategic Alternatives

December 19, 2007:
The GI Company Expands Its Scientific Advisory Board

The GI Company is pleased to have had the opportunity to present at the following conferences:

BIO Europe, Madrid - April 7-9, 2008
ASCO, Chicago - May 30 - June 3, 2008
BIO International, San Diego - June 17-20, 2008
MASCC/ISOO International Symposium, Houston - June 26-28, 2008